A very close margin of ≤1mm predicts a poor outcome in resected buccal cancer patients with a pathological margin of ≤3mm

Tzu Chi Medical Journal

Volumn 23, Issue 4, 2011, Pages 123-130

  Tsai, Wei Ta ^a   Lee, Moon Sing ^a,b   Hung, Shih Kai ^a,b   Chiou, Wen Yen ^a,b   Huang, Tze Ta ^a,b   Tseng, Chih En ^a,b   Chang, Shu Mei ^a,b   Hsu, Feng Chun ^a   Su, Yu Chieh ^a,b   Li, Szu Chi ^a,b   Hsu, Wen Lin ^a,b   Liu, Dai Wei ^a,b   Lin, Hon Yi ^a,b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Buccal mucosa carcinoma; Chemoradiotherapy; Close margin; Locoregional control; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DISEASE SPECIFIC SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; TREATMENT FAILURE;

EID: 84855320857     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcmj.2011.10.005     Document Type: Article

References (21)

1. Taiwan: department of health 2008, Cancer registry annual report Taiwan, [accessed 07.05.11]. http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx%3FNo%3D201105200001.
2. NCCN clinical practice guidelines in oncology (NCCN guidelines™): head and neck cancers 2011, Nccn.Org, NCCN.org, [accessed 07.05.11]. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
3. Nason R.W., Binahmed A., Pathak K.A., Abdoh A.A., Sandor G.K. What is the adequate margin of surgical resection in oral cancer?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 5:625-629.
4. Bernier J., Cooper J.S., Pajak T.F., Van Glabbeke M., Bourhis J., Forastiere A., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005, 10:843-850.
5. Chiou W.Y., Lin H.Y., Hsu F.C., Lee M.S., Ho H.C., Su Y.C., et al. Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence. Radiat Oncol 2010, 5:79.
6. Liao C.T., Wang H.M., Ng S.H., Yen T.C., Lee L.Y., Hsueh C., et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 2006, 8:800-809.
7. Brandwein-Gensler M., Teixeira M.S., Lewis C.M., Lee B., Rolnitzky L., Hille J.J., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005, 2:167-178.
8. Liao C.T., Wang H.M., Chang J.T., Lin C.Y., Ng S.H., Huang S.F., et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010, 2:421-429.
9. Liao C.T., Chang J.T., Wang H.M., Ng S.H., Hsueh C., Lee L.Y., et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 2008, 3:915-922.
10. Ota Y., Aoki T., Karakida K., Otsuru M., Kurabayashi H., Sasaki M., et al. Determination of deep surgical margin based on anatomical architecture for local control of squamous cell carcinoma of the buccal mucosa. Oral Oncol 2009, 7:605-609.
11. Lin C.S., Jen Y.M., Cheng M.F., Lin Y.S., Su W.F., Hwang J.M., et al. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck 2006, 2:150-157.
12. Greene F.L. AJCC cancer staging atlas 2006, Springer, New York, pp. 29-40. 6th ed.
13. Diaz E.M., Holsinger F.C., Zuniga E.R., Roberts D.B., Sorensen D.M. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients. Head Neck 2003, 4:267-273.
14. Strome S.E., To W., Strawderman M., Gersten K., Devaney K.O., Bradford C.R., et al. Squamous cell carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg 1999, 3:375-379.
15. Sieczka E., Datta R., Singh A., Loree T., Rigual N., Orner J., et al. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control?. Am J Otolaryngol 2001, 6:395-399.
16. Jing J., Li L., He W., Sun G. Prognostic predictors of squamous cell carcinoma of the buccal mucosa with negative surgical margins. JOral Maxillofac Surg 2006, 6:896-901.
17. Sutton D.N., Brown J.S., Rogers S.N., Vaughan E.D., Woolgar J.A. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003, 1:30-34.
18. Upile T., Fisher C., Jerjes W., El Maaytah M., Searle A., Archer D., et al. The uncertainty of the surgical margin in the treatment of head and neck cancer. Oral Oncol 2007, 4:321-326.
19. Supic G., Kozomara R., Jovic N., Zeljic K., Magic Z. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Oral Oncol 2011, 47:702-708.
20. Steyerberg E.W. Clinical prediction models: a practical approach to development, validation and updating 2009, Springer, New York, p. 77.
21. O'Quigley J. Proportional hazards regression 2006, Springer, New York, p.120.